Ferrer Miguel, Buey Berta, Grasa Laura, Mesonero Jose Emilio, Latorre Eva
Departamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza, Spain.
Departamento de Farmacología, Fisiología y Medicina Legal y Forense, Facultad de Veterinaria, Universidad de Zaragoza, Zaragoza, Spain.
Cell Stress Chaperones. 2024 Dec;29(6):769-776. doi: 10.1016/j.cstres.2024.11.002. Epub 2024 Nov 14.
Inflammatory bowel diseases (IBDs) are driven by an exaggerated inflammatory response, which leads to a marked increase in oxidative stress. This, in turn, exacerbates the inflammatory process and causes significant cellular and tissue damage. Intestinal dysbiosis, a common observation in IBD patients, alters the production of bacterial metabolites, including short-chain fatty acids (SCFAs), which are key by-products of dietary fiber fermentation. While the role of SCFAs in intestinal physiology is still being elucidated, this study aimed to investigate their effects on intestinal oxidative stress, particularly under inflammatory conditions induced by the proinflammatory mediator tumor necrosis factor alpha (TNF-α). The Caco-2/TC7 cell line was employed as an in vitro model of the intestinal epithelium, and the cells were treated with a range of SCFAs, including acetate, propionate, and butyrate. The levels of protein and lipid oxidation were quantified, as well as the activity of antioxidant enzymes. Our findings demonstrate that microbiota-derived SCFAs can effectively mitigate TNF-α-induced oxidative stress by modulating antioxidant enzyme activity. The proinflammatory mediator TNF-α induces lipid peroxidation by inhibiting catalase and glutathione peroxidase activities. SCFAs are able to upregulate antioxidant enzyme activity to restore lipid oxidative levels. These results underscore the critical role of the gut microbiota in maintaining intestinal homeostasis and highlight the therapeutic potential of SCFAs in managing oxidative stress-related pathologies.
炎症性肠病(IBDs)由过度的炎症反应驱动,这会导致氧化应激显著增加。反过来,这又会加剧炎症过程并造成严重的细胞和组织损伤。肠道微生物群失调是IBD患者常见的现象,它会改变细菌代谢产物的产生,包括短链脂肪酸(SCFAs),这些是膳食纤维发酵的关键副产物。虽然SCFAs在肠道生理学中的作用仍在阐明中,但本研究旨在探讨它们对肠道氧化应激的影响,特别是在促炎介质肿瘤坏死因子α(TNF-α)诱导的炎症条件下。采用Caco-2/TC7细胞系作为肠上皮的体外模型,并用一系列SCFAs(包括乙酸盐、丙酸盐和丁酸盐)处理细胞。对蛋白质和脂质氧化水平以及抗氧化酶的活性进行了定量。我们的研究结果表明,微生物群衍生的SCFAs可以通过调节抗氧化酶活性有效减轻TNF-α诱导的氧化应激。促炎介质TNF-α通过抑制过氧化氢酶和谷胱甘肽过氧化物酶的活性诱导脂质过氧化。SCFAs能够上调抗氧化酶活性以恢复脂质氧化水平。这些结果强调了肠道微生物群在维持肠道稳态中的关键作用,并突出了SCFAs在管理氧化应激相关疾病方面的治疗潜力。